Remove ampersand
article thumbnail

NeoGenomics Buys Ex-Novartis Cancer Lab Genoptix for $125M, Stock

Xconomy

The buyout comes almost two years after Carlsbad, CA-based Genoptix was bought from Novartis (NYSE: NVS ) by a pair of private investment firms, Ampersand Capital Partners and 1315 Capital, and a management group for an undisclosed sum in January 2017. Joseph Limber became the CEO of the company.

article thumbnail

Helix Medical Buys MedVenture Technology

socalTECH

a medical device design, development, and manufacturing company. MedVenture was owned by private equity firm Ampersand Capital Partners. Carpinteria-based Helix Medical , a manufacturer for the medical device and healthcare industry, has acquired MedVenture Technology Corp. , Financial terms of the buy were not disclosed.